BEGIN:VCALENDAR
VERSION:2.0
PRODID:researchseminars.org
CALSCALE:GREGORIAN
X-WR-CALNAME:researchseminars.org
BEGIN:VEVENT
SUMMARY:Peter Kharchenko (Harvard University)
DTSTART:20210503T141000Z
DTEND:20210503T144000Z
DTSTAMP:20260404T095547Z
UID:ComputationalBiology/1
DESCRIPTION:Title: <a href="https://stable.researchseminars.org/talk/Compu
 tationalBiology/1/">Bayesian segmentation of spatially resolved transcript
 omics data</a>\nby Peter Kharchenko (Harvard University) as part of Comput
 ational Biology Symposium\n\n\nAbstract\nSpatial transcriptomics is an eme
 rging stack of technologies\, which adds spatial dimension to conventional
  single-cell RNA-sequencing. New protocols\, based on in situ sequencing o
 r multiplexed RNA fluorescent in situ hybridization register positions of 
 single molecules in fixed tissue slices. Analysis of such data at the leve
 l of individual cells\, however\, requires accurate identification of cell
  boundaries. While many existing methods are able to approximate cell cent
 er positions using nuclei stains\, current protocols do not report robust 
 signal on the cell membranes\, making accurate cell segmentation a key bar
 rier for downstream analysis and interpretation of the data. To address th
 is challenge\, we developed a tool for Bayesian Segmentation of Spatial Tr
 anscriptomics Data (Baysor)\, which optimizes segmentation considering the
  likelihood of transcriptional composition\, size and shape of the cell. T
 he Bayesian approach can take into account nuclear or cytoplasm staining\,
  however can also perform segmentation based on the detected transcripts a
 lone. We show that Baysor segmentation can in some cases nearly double the
  number of the identified cells\, while reducing contamination. Importantl
 y\, we demonstrate that Baysor performs well on data acquired using five d
 ifferent spatially-resolved protocols\, making it a useful general tool fo
 r analysis of high-resolution spatial data.\n
LOCATION:https://stable.researchseminars.org/talk/ComputationalBiology/1/
END:VEVENT
BEGIN:VEVENT
SUMMARY:Smita Krishnaswamy (Yale University)
DTSTART:20210503T144500Z
DTEND:20210503T151500Z
DTSTAMP:20260404T095547Z
UID:ComputationalBiology/2
DESCRIPTION:Title: <a href="https://stable.researchseminars.org/talk/Compu
 tationalBiology/2/">Geometric and Topological Approaches to Representation
  Learning in Biomedical Data</a>\nby Smita Krishnaswamy (Yale University) 
 as part of Computational Biology Symposium\n\n\nAbstract\nHigh-throughput\
 , high-dimensional data has become ubiquitous in the biomedical\, health a
 nd social sciences as a result of breakthroughs in measurement technologie
 s and data collection. While these large datasets containing millions of o
 bservations of cells\, peoples\, or brain voxels  hold great potential for
  understanding generative state space of the data\, as well as drivers of 
 differentiation\, disease and progression\, they also pose new challenges 
 in terms of noise\, missing data\, measurement artifacts\, and the so-call
 ed “curse of dimensionality.” In this talk\, I will cover data geometr
 ic and topological approaches to understanding the shape and structure of 
 the data.  First\, we show how diffusion geometry and deep learning can be
   used to obtain useful representations of the data that enable denoising 
 (MAGIC)\, dimensionality reduction (PHATE)\, and factor analysis (Archetyp
 al Analysis Network) of the data.  Next we will show how to learn dynamics
  from static snapshot data by using a manifold-regularized neural ODE-base
 d optimal transport (TrajectoryNet). Finally\, we cover a novel approach t
 o combine diffusion geometry with topology to extract multi-granular featu
 res from the data (Diffusion Condensation and Multiscale PHATE) to assist 
 in differential and predictive analysis. On the flip side\, we also create
  a manifold geometry from topological descriptors\, and show its applicati
 ons to neuroscience. Together\, we will show a complete framework for expl
 oratory and unsupervised analysis of big biomedical data.\n
LOCATION:https://stable.researchseminars.org/talk/ComputationalBiology/2/
END:VEVENT
BEGIN:VEVENT
SUMMARY:Meromit Singer (Harvard Medical School)
DTSTART:20210503T152000Z
DTEND:20210503T155000Z
DTSTAMP:20260404T095547Z
UID:ComputationalBiology/3
DESCRIPTION:Title: <a href="https://stable.researchseminars.org/talk/Compu
 tationalBiology/3/">Utilizing coupled single-cell RNA-seq and TCR-seq to r
 eveal Th17 systemic dynamics during homeostasis and disease</a>\nby Meromi
 t Singer (Harvard Medical School) as part of Computational Biology Symposi
 um\n\n\nAbstract\nIn this talk we will describe a systemic study of the tr
 anscriptional and clonal characteristics and function of Th17 cells throug
 hout multiple mouse organs\, as revealed by coupled single-cell RNA-seq an
 d TCR-seq\, and validated in follow-up experiments in the lab. We will des
 cribe how we utilized 84\,000 tissue Th17 cells profiled during homeostasi
 s and disease to characterize their heterogeneity\, plasticity\, and migra
 tion at homeostasis and during CNS autoimmunity. We discovered a homeostat
 ic Th17 cell population\, that is induced by the intestinal microbiota\, i
 s present in both lymphoid organs and the intestine\, and expresses IL-17.
  We discovered that during EAE this homeostatic population gives rise to a
  pathogenic Th17 cell population\, that migrates specifically through the 
 draining lymph nodes and the spleen to the CNS\, and highly expresses a sp
 ecific subset of cytokines. \nIn this talk we will emphasize how coupled s
 ingle-cell RNA-seq and TCR data was used to generate hypotheses regarding 
 cell subtype characterization and T cell clonality and migration\, and how
  such hypotheses were followed-up on experimentally.\n
LOCATION:https://stable.researchseminars.org/talk/ComputationalBiology/3/
END:VEVENT
BEGIN:VEVENT
SUMMARY:John Marioni (EMBL-EBI)
DTSTART:20210503T155500Z
DTEND:20210503T162500Z
DTSTAMP:20260404T095547Z
UID:ComputationalBiology/4
DESCRIPTION:by John Marioni (EMBL-EBI) as part of Computational Biology Sy
 mposium\n\nAbstract: TBA\n
LOCATION:https://stable.researchseminars.org/talk/ComputationalBiology/4/
END:VEVENT
BEGIN:VEVENT
SUMMARY:Uri Alon (Weizmann Institute)
DTSTART:20210503T172500Z
DTEND:20210503T175500Z
DTSTAMP:20260404T095547Z
UID:ComputationalBiology/5
DESCRIPTION:Title: <a href="https://stable.researchseminars.org/talk/Compu
 tationalBiology/5/">Design principles of hormone circuits</a>\nby Uri Alon
  (Weizmann Institute) as part of Computational Biology Symposium\n\nAbstra
 ct: TBA\n
LOCATION:https://stable.researchseminars.org/talk/ComputationalBiology/5/
END:VEVENT
BEGIN:VEVENT
SUMMARY:Eran Segal (Weizmann Institute)
DTSTART:20210503T180000Z
DTEND:20210503T183000Z
DTSTAMP:20260404T095547Z
UID:ComputationalBiology/6
DESCRIPTION:Title: <a href="https://stable.researchseminars.org/talk/Compu
 tationalBiology/6/">Harnessing big data for personalized medicine</a>\nby 
 Eran Segal (Weizmann Institute) as part of Computational Biology Symposium
 \n\n\nAbstract\nThe recent availability of diverse health data resources o
 n large cohorts of human individuals presents many challenges and opportun
 ities. I will present our work aimed at developing machine learning algori
 thms for predicting future onset of disease and identifying causal drivers
  of disease based on nationwide electronic health record data as well as d
 ata from high-throughput omics profiling technologies such as genetics\, m
 icrobiome\, and metabolomics. Our models provide novel insights into poten
 tial drivers of obesity\, diabetes\, and heart disease\, and identify hund
 reds of novel markers at the microbiome\, metabolite\, and immune system l
 evel. Overall\, our predictive models can be translated into personalized 
 disease prevention and treatment plans\, and to the development of new the
 rapeutic modalities based on metabolites and the microbiome.\n
LOCATION:https://stable.researchseminars.org/talk/ComputationalBiology/6/
END:VEVENT
BEGIN:VEVENT
SUMMARY:Martin Hemberg (Brigham and Women’s Hospital)
DTSTART:20210503T183500Z
DTEND:20210503T190500Z
DTSTAMP:20260404T095547Z
UID:ComputationalBiology/7
DESCRIPTION:Title: <a href="https://stable.researchseminars.org/talk/Compu
 tationalBiology/7/">Searching for alien DNA – characterization of sequen
 ces that are not present in the DNA</a>\nby Martin Hemberg (Brigham and Wo
 men’s Hospital) as part of Computational Biology Symposium\n\n\nAbstract
 \nNullomers and nullpeptides are short DNA or amino acid sequences that ar
 e absent from a genome or proteome\, respectively. One potential cause for
  their absence could be that they have a detrimental impact on an organism
 . Here\, we identified all possible nullomers and nullpeptides in the geno
 mes and proteomes of over thirty species and show that a significant propo
 rtion of these sequences are under negative selection. We assign nullomers
  to different functional categories (coding sequences\, exons\, introns\, 
 5’UTR\, 3’UTR\, regulatory regions and promoters) and show that nullom
 ers from coding sequences and promoters are most likely to be selected aga
 inst. Similarly\, we find that regulatory regions and transcription factor
  binding sites harbor more mutations resulting in nullomers than expected.
  Further analysis of coding regions also reveals specific pathways where m
 utations are more likely to result in nullomers or nullpeptides. Utilizing
  variants in the human population\, we annotate variant-associated nullome
 rs\, highlighting their potential use as DNA ‘fingerprints’.\n
LOCATION:https://stable.researchseminars.org/talk/ComputationalBiology/7/
END:VEVENT
BEGIN:VEVENT
SUMMARY:Elana Fertig (Johns Hopkins)
DTSTART:20210503T191000Z
DTEND:20210503T194000Z
DTSTAMP:20260404T095547Z
UID:ComputationalBiology/8
DESCRIPTION:Title: <a href="https://stable.researchseminars.org/talk/Compu
 tationalBiology/8/">Uncovering hidden sources of transcriptional dysregula
 tion arising from inter- and intra-tumor heterogeneity.</a>\nby Elana Fert
 ig (Johns Hopkins) as part of Computational Biology Symposium\n\n\nAbstrac
 t\nHeterogeneity poses a major challenge in translational research. For ex
 ample\, inter-tumor heterogeneity limits the biomarker discovery and intra
 -tumor heterogeneity enables therapeutic resistance. Moreover\, in some ca
 ncers driver mutations are insufficient to account for the widespread tran
 scriptional variation responsible for these outcomes. Thus\, new computati
 onal tools to model transcriptional variation are essential. To address th
 is we develop an innovative computational framework\, Expression Variation
  Analysis (EVA)\, to model transcriptional dysregulation in cancer. Briefl
 y\, EVA quantifies transcriptional heterogeneity for one set of samples or
  cells from one phenotype using the expected dissimilarity between pairs o
 f expression profiles. U-statistics theory can then quantify the statistic
 al significance of the difference in transcriptional heterogeneity between
  phenotypes. We apply EVA to perform a comprehensive characterization of t
 ranscriptional variation in head and neck squamous cell carcinoma (HNSCC).
  At a pathway level\, transcriptional variation in HNSCC tumors is higher 
 than normal controls. Applying EVA to integrate ChIP-seq data with RNA-seq
  reveals that these pervasive transcriptional differences occur in enhance
 rs. Similarly\, applying EVA at a gene level to model splicing reveals mor
 e heterogeneity in transcript usage in tumor samples than normals. HPV- HN
 SCC tumors are unique in having mutations in genes that regulate the splic
 ing machinery\, and the HPV- tumors with these alterations have a greater 
 number of dysregulated splice variants than those without. Nonetheless\, t
 he EVA analysis identifies a similar number of alternative splice variants
  in HPV+ as HPV- tumors suggesting an alternative mechanism of transcripti
 onal heterogeneity in HPV+ disease. Adapting EVA to single cell data demon
 strates that increased fibroblast composition is associated with greater v
 ariation in immune pathway activity in HNSCC. Moreover\, we observe greate
 r transcriptional heterogeneity in HNSCC primary tumors than lymph node me
 tastasis consistent with a clonal outgrowth. We demonstrate that the stati
 stical framework from EVA enables differential heterogeneity analysis in H
 NSCC ranging from pathway dysregulation\, splice variation\, epigenetic re
 gulation\, and single cell analysis. This algorithm provides a critical fr
 amework to model the hidden multi-molecular mechanisms underlying the comp
 lex patient outcomes that are pervasive in cancer.\n
LOCATION:https://stable.researchseminars.org/talk/ComputationalBiology/8/
END:VEVENT
END:VCALENDAR
